Advertisement

A Video Study of Drop Instillation in Both Glaucoma and Retina Patients with Visual Impairment

Published:August 08, 2011DOI:https://doi.org/10.1016/j.ajo.2011.05.015

      Purpose

      To compare self-administration of drops in both visually impaired glaucoma subjects and retina subjects.

      Design

      Prospective, observational study.

      Methods

      Setting: Distinct glaucoma and retina practices. Study Population: Subjects with glaucoma or retinal diseases with visual acuity of 20/60 or worse in 1 eye, significant field loss, or both. Observation Procedures: Subjects were video recorded self-instilling a drop onto the worse eye. Main Outcome Measure: Proper instillation of eye drop onto ocular surface.

      Results

      We included 409 subjects (205 glaucoma, 204 retina). Differences between the groups included the following: glaucoma subjects included fewer females (P = .05), included fewer white persons (P < .005), had worse visual acuity (P < .005), had less self-reported arthritis (P < .05), were younger (P < .005), and had more previous exposure to drop use (P < .005). Glaucoma subjects had more bilateral impairment (60% vs 42%; P < .0005). Retina subjects instilled more drops (1.7 vs 1.4; P = .02) and more frequently touched the bottle to the eye (47% vs 33%; P = .003). Of subjects claiming not to miss the eye, nearly one third from each group (P = .32) actually missed. Approximately one third of each group could not get a drop onto the eye (30% retina vs 29% glaucoma; P = .91). Among subjects placing 1 drop onto the eye without touching the adnexae, there was a trend for glaucoma patients to perform better, although both groups did poorly (success, 39% glaucoma vs 31% retina; P = .09).

      Conclusions

      Among visually impaired subjects, regardless of cause, drop administration was a problem. Both groups wasted drops, contaminated bottles, and had inaccurate perception of their abilities. This has implications for future therapeutic delivery systems.
      To read this article in full you will need to make a payment

      Subscribe:

      Subscribe to American Journal of Ophthalmology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Stone J.L.
        • Robin A.L.
        • Novack G.D.
        • et al.
        An objective evaluation of eyedrop instillation in patients with glaucoma.
        Arch Ophthalmol. 2009; 127: 732-736
        • Hennessy A.L.
        • Katz J.
        • Covert D.
        • Protzko C.
        • Robin A.L.
        Videotaped evaluation of eye drop instillation in glaucoma patients with visual impairment or moderate to severe visual field loss.
        Ophthalmology. 2010; 117: 2345-2352
        • Congdon N.
        • O'Colmain B.
        • Klaver C.
        • et al.
        • Eye Diseases Prevalence Research Group
        Causes and prevalence of visual impairment among adults in the United States.
        Arch Ophthalmol. 2004; 122: 477-485
        • Urquhart J.
        • Vrijens B.
        New findings about patient adherence to prescribed drug dosing regimens: an introduction to pharmionics.
        Eur J Hosp Pharm Science. 2005; 11: 103-106
        • Vrijens B.
        • Vincze G.
        • Kristanto P.
        • et al.
        Adherence to prescribed antihypertensive drug treatments: longitudinal study of electronically compiled dosing histories.
        BMJ. 2008; 336: 1114-1117
        • Aptel F.
        • Masset H.
        • Burillon C.
        • et al.
        The influence of disease severity on quality of eyedrop administration in patients with glaucoma or ocular hypertension.
        Br J Ophthalmol. 2009; 93: 700-701
        • Hodapp E.
        • Parrish R.K.
        • Anderson D.R.
        Clinical decisions in glaucoma.
        Mosby, St. Louis1993
        • Dietlein T.S.
        • Jordan J.F.
        • Lüke C.
        • et al.
        Self-application of single-use eyedrop containers in an elderly population: comparisons with standard eyedrop bottle and with younger patients.
        Acta Ophthalmol. 2008; 86: 856-859
        • Kholdebarin R.
        • Campbell R.J.
        • Jin Y.
        • Buys Y.M.
        Multicenter study of compliance and drop administration in glaucoma.
        Can J Ophthalmol. 2008; 43: 454-461
        • Kass M.A.
        • Hodapp E.
        • Gordon M.
        • et al.
        Patient administration of eyedrops: observation.
        Ann Ophthalmol. 1982; 14: 889-893
        • Patel S.C.
        • Spaeth G.
        Compliance in patients prescribed eyedrops for glaucoma.
        Ophthalmic Surg. 2005; 26: 233-236
        • Brown M.
        • Brown G.
        • Spaeth G.
        Improper topical self-administration of ocular medication among patients with glaucoma.
        Can J Ophthalmol. 1984; 19: 2-5
        • Dickinson C.
        • Shim M.
        The influence of manual dexterity on reading speed with a hand-held magnifier.
        Invest Ophthalmol Vis Sci. 2007; 48: 4368-4374
        • Burns E.
        • Mulley G.P.
        Practical problems with eye-drops among elderly ophthalmology outpatients.
        Age Aging. 1992; 21: 168-170
        • Konstas A.G.
        • Maskaleris G.
        • Gratsonidis S.
        • Sardelli C.
        Compliance and viewpoints of glaucoma patients in Greece.
        Eye. 2000; 14: 752-756
        • Kern T.S.
        • Miller C.M.
        • Du Y.
        • et al.
        Topical administration of nepafenac inhibits diabetes-induced retinal microvascular disease and underlying abnormalities of retinal metabolism and physiology.
        Diabetes. 2007; 56: 373-379
        • Koevary S.B.
        Pharmacokinetics of topical ocular drug delivery: potential uses for the treatment of diseases of the posterior segment and beyond.
        Curr Drug Metab. 2003; 4: 213-222
        • Koevary S.B.
        • Nussey J.
        • Kern T.S.
        Long-term, topical insulin administration increases the severity of retinal vascular pathology in streptozotocin-induced diabetic rats.
        Optometry. 2007; 78: 574-581
        • Lambiase A.
        • Coassin M.
        • Tirassa P.
        • Mantelli F.
        • Aloe L.
        Nerve growth factor eye drops improve visual acuity and electrofunctional activity in age-related macular degeneration: a case report.
        Ann Ist Super Sanita. 2009; 45: 439-442
        • Oharazawa H.
        • Igarashi T.
        • Yokota T.
        • et al.
        Protection of the retina by rapid diffusion of hydrogen: administration of hydrogen-loaded eye drops in retinal ischemia-reperfusion injury.
        Invest Ophthalmol Vis Sci. 2010; 51: 487-492
        • Warren K.A.
        • Fox J.E.
        Topical nepafenac as an alternate treatment for cystoid macular edema in steroid responsive patients.
        Retina. 2008; 28: 1427-1434
        • Loftsson T.
        • Stefansson E.
        Cyclodextrins in eye drop formulations: enhanced topical delivery of corticosteroids to the eye.
        Acta Ophthalmol Scand. 2002; 80: 144-150
        • Bhavsar A.R.
        • Googe J.M.
        • Stockdale C.R.
        • et al.
        Risk of endophthalmitis after intravitreal drug injection when topical antibiotics are not required: the diabetic retinopathy clinical research network laser-ranibizumab-triamcinolone clinical trials.
        Arch Ophthalmol. 2009; 127: 1581-1583